Skip to main content
 

Biosimilars Forum Commends FDA Commissioner For Raising Awareness Of Biosimilars

WASHINGTON, D.C., July 12, 2018 – The Biosimilars Forum commends Food and Drug Administration (FDA) Commissioner Scott Gottlieb for continuing to support the growth of a vibrant biosimilars market during his latest Twitter #SundayTweetorial.

“The first step to encouraging greater uptake of biosimilars is increasing awareness across the medical community,” said Juliana M. Reed, President of the Biosimilars Forum. “Having Commissioner Gottlieb use his platform to share information about biosimilars with physicians, patients and prescribers about the benefits of biosimilars will help realize the great promise that these innovative drugs hold. And it reinforces the clear commitment of this administration to support the growth of biosimilars throughout the U.S.”

About the Biosimilars Forum

The Biosimilars Forum is a nonprofit organization whose mission is to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The founding members of the Biosimilars Forum represent the majority of companies with the most significant U.S. biosimilars development portfolios.

To learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org, @USbiosimilars, or Facebook/USBiosimilars to follow related conversations and join the dialogue.

Contact:
Anthony Hogrebe, Marathon Strategies
Anthony@marathonstrategies.com

Date

Thursday, July 12, 2018